2000

Oct 3, 2000
Guidant Announces FDA Approval of its MULTI-LINK TETRA Coronary Stent System

Innovative, New System Represents Guidant''s Eighth Major Product Approval in Four Months. Market Anticipation of New Coronary Stent Impacts Third Quarter Revenues Indianapolis, Ind. and Santa...

Sep 29, 2000
Guidant Supports UK Institute''s Guidance on Implantable Defibrillators

National Institute for Clinical Excellence Recommends Three-Fold Increase in Defibrillator Use Indianapolis, IN - Guidant Corporation (NYSE and PCX: GDT), a global leader in the medical technology...

Sep 22, 2000
Guidant Launches Clinical Trial to Study Iliac Artery Stenting as Alternative to Traditional Treatment with Angioplasty

Indianapolis, IN - Guidant Corporation (NYSE and PCX: GDT), a world leader in the treatment of coronary and peripheral vascular disease, today announced the start of a clinical trial to determine...

Sep 21, 2000
Guidant CEO Ron Dollens Named to the Board of Directors of the Alliance for Aging Research

Indianapolis, IN - Guidant Corporation (NYSE and PCX: GDT) today announced that Guidant president and CEO Ron Dollens has been named to the board of directors of the Alliance for Aging Research....

Sep 19, 2000
Guidant Continues to Evaluate Impulse Dynamics Heart Failure Technology

Company to Make Acquisition Decision After Completing Comprehensive Investigation Indianapolis, IN - Guidant Corporation (NYSE and PCX: GDT), a world leader in the medical technology industry,...

Show 5102550100 per page
Top